DSM and Haixing acquire majority stake in Inner Mongolia Rainbow Biotechnology

DSM and Zhejiang Haixing Investment Co. Ltd acquired a majority equity stake in Inner Mongolia Rainbow Biotechnology Co. Ltd, renamed DSM Rainbow (Inner Mongolia) Biotechnology Co., Ltd. DSM owns 65%, Haixing 27%, and the founder 8%.

“This is an important strategic investment, which expands both our manufacturing capacity and innovation competences, enabling us to deliver on our strategy to become a leading and fast-growing player in the hydrocolloids market.”our-company.dsm-firmenich.com

• 1 source
• our-company.dsm-firmenich.comDSM and Haixing strengthen hydrocolloids business with acquisition of Inner Mongolia Rainbow Biotechnology Co., Ltd. (China) | DSMNov 10, 2017

Summarized from public sources; check the original articles before acting on it.